MoneyWorks4Me

Dr. Reddy’s Laboratories informs about press release

27 Feb 2023 Evaluate

Dr. Reddy’s Laboratories has informed that it enclosed a Press Release on ‘Dr. Reddy's Laboratories announces agreement to acquire Mayne Pharma’s U.S. generic prescription product portfolio’.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1843.00
Dr. Reddys Labs. 1152.00
Cipla 1352.65
Lupin 2072.95
Zydus Lifesciences 1113.00
View more..